CUE Cue Biopharma, Inc.
Nasdaq · SEC CIK 1645460 · EDGAR
- Bought, last 12 months
- $99.7K 1 purchases by 1 insiders
- Sold, last 12 months
- $2.04M 3 sales by 3 insiders
- Filings on record
- 115 since 2021-09-27, latest 2026-08-28 17:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Lin Shao-Lee | CEO, Dir | — | $1.61M |
| Ray Sumita | Chief Legal Compliance Off, Corp. Sec | — | $265.6K |
| Meluzio Michael Vincent | VP, Prin. Accounting Off | — | $169.3K |
| Sarraf Pasha | Dir | $99.7K | — |
| Meehan Viola Mong | Dir | — | — |
| Borie Dominique Christian | Chief Medical Off, Head of Research, Development | — | — |
| Garzone Pamela | Dir | — | — |
| Camardo Daniel A. | Dir | — | — |
| Ahlers James M | CFO | — | — |
Transactions 52
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-08-28 17:05 | 2026-07-09 | CUE | Sarraf Pasha | Dir | A - Grant | $0.00 | +18.4K | 29.2K | +170% | $0 |
| A | 2026-08-28 17:04 | 2026-07-09 | CUE | Garzone Pamela | Dir | A - Grant | $0.00 | +18.9K | 18.9K | New | $0 |
| D | 2026-08-17 18:22 | 2026-08-13 | CUE | Ray Sumita | Chief Legal Compliance Off, Corp. Sec | M - OptEx | $0.00 | +18.2K | 127.4K | +17% | $0 |
| DM | 2026-08-17 18:22 | 2026-08-13 | CUE | Ray Sumita | Chief Legal Compliance Off, Corp. Sec | S - Sale+OE | $30.09 | -8,829 | 118.5K | -7% | -$265.6K |
| D | 2026-08-17 18:19 | 2026-08-13 | CUE | Meluzio Michael Vincent | VP, Prin. Accounting Off | M - OptEx | $0.00 | +13.6K | 54.6K | +33% | $0 |
| DM | 2026-08-17 18:19 | 2026-08-13 | CUE | Meluzio Michael Vincent | VP, Prin. Accounting Off | S - Sale+OE | $30.09 | -5,628 | 49.0K | -10% | -$169.3K |
| D | 2026-08-14 20:46 | 2026-08-12 | CUE | Lin Shao-Lee | CEO, Dir | M - OptEx | $0.00 | +109.2K | 764.3K | +17% | $0 |
| DM | 2026-08-14 20:46 | 2026-08-12+ | CUE | Lin Shao-Lee | CEO, Dir | S - Sale+OE | $27.58 | -58.3K | 706.0K | -8% | -$1.61M |
| D | 2026-08-03 16:19 | 2026-07-30 | CUE | Ahlers James M | CFO | A - Grant | $0.00 | +25.5K | 25.5K | New | $0 |
| D | 2026-07-15 18:59 | 2026-07-13 | CUE | Borie Dominique Christian | Chief Medical Off, Head of Research, Development | A - Grant | $0.00 | +31.5K | 31.5K | New | $0 |
| 2026-07-10 19:37 | 2026-07-09 | CUE | Garzone Pamela | Dir | A - Grant | $0.00 | +21.8K | 21.8K | New | $0 | |
| 2026-07-10 19:37 | 2026-07-09 | CUE | Camardo Daniel A. | Dir | A - Grant | $0.00 | +21.8K | 21.8K | New | $0 | |
| 2026-07-10 19:36 | 2026-07-09 | CUE | Sarraf Pasha | Dir | A - Grant | $0.00 | +21.8K | 32.6K | +202% | $0 | |
| 2026-07-10 19:35 | 2026-07-09 | CUE | Meehan Viola Mong | Dir | A - Grant | $0.00 | +21.8K | 21.8K | New | $0 | |
| D | 2026-07-10 19:34 | 2026-07-09 | CUE | Meluzio Michael Vincent | VP, Prin. Accounting Off | A - Grant | $0.00 | +40.9K | 40.9K | New | $0 |
| D | 2026-07-10 19:33 | 2026-07-09 | CUE | Ray Sumita | Chief Legal Compliance Off, Corp. Sec | A - Grant | $0.00 | +54.6K | 109.2K | +100% | $0 |
| D | 2026-07-10 19:32 | 2026-07-09 | CUE | Lin Shao-Lee | CEO, Dir | A - Grant | $0.00 | +327.5K | 655.1K | +100% | $0 |
| D | 2026-05-07 16:00 | 2026-05-03 | CUE | Lin Shao-Lee | CEO, Dir | A - Grant | $0.00 | +327.5K | 327.5K | New | $0 |
| M | 2026-01-02 | 2025-12-30 | CUE | Sarraf Pasha | Dir | P - Purchase | $0.3079 | +323.9K | 246.4K | New | +$99.7K |
| 2024-12-18 | 2024-12-16 | CUE | PASSERI DANIEL R | CEO, Dir | P - Purchase | $1.03 | +30.0K | 164.6K | +22% | +$30.9K | |
| 2023-08-29 | 2023-08-25 | CUE | Suri Anish | Pres AND CSO | P - Purchase | $2.76 | +4,000 | 135.6K | +3% | +$11.0K | |
| 2023-08-16 | 2023-08-14 | CUE | PASSERI DANIEL R | CEO, Dir | P - Purchase | $2.86 | +3,000 | 134.6K | +2% | +$8,580 | |
| D | 2023-03-27 | 2023-03-23 | CUE | Kiener Peter A | Dir | M - OptEx | $2.86 | +9,682 | 9,682 | New | +$27.7K |
| D | 2023-03-27 | 2023-03-23 | CUE | Kiener Peter A | Dir | S - Sale+OE | $3.28 | -9,325 | 357 | -96% | -$30.6K |
| D | 2022-08-23 | 2022-08-21 | CUE | Millar Kerri-Ann | CFO | M - OptEx | — | +6,667 | 17.1K | +64% | — |
| D | 2022-08-23 | 2022-08-22 | CUE | Millar Kerri-Ann | CFO | F - Tax | $3.05 | -2,828 | 14.3K | -17% | -$8,625 |
| D | 2022-06-16 | 2022-06-14 | CUE | Gray Cameron | Dir | X - OptEx | $2.70 | +61.1K | 738.6K | +9% | +$165.0K |
| D | 2022-06-16 | 2022-06-14 | CUE | Gray Cameron | Dir | F - Tax | $3.20 | -51.6K | 687.0K | -7% | -$165.0K |
| 2022-05-31 | 2022-05-27 | CUE | Morich Frank | Dir | P - Purchase | $3.75 | +28.0K | 28.0K | New | +$105.0K | |
| MI | 2022-05-25 | 2022-05-23+ | CUE | Fletcher Aaron G.L. | Dir | P - Purchase | $3.47 | +205.0K | 940.0K | +28% | +$711.7K |
| D | 2022-04-04 | 2022-03-31 | CUE | PASSERI DANIEL R | CEO, Dir | F - Tax | $4.88 | -32.1K | 141.6K | -18% | -$156.8K |
| D | 2022-04-04 | 2022-03-31 | CUE | PASSERI DANIEL R | CEO, Dir | G - Gift | $0.00 | -10.0K | 131.6K | -7% | $0 |
| D | 2022-04-04 | 2022-03-31 | CUE | PASSERI DANIEL R | CEO, Dir | M - OptEx | — | +75.0K | 173.7K | +76% | — |
| D | 2022-04-04 | 2022-03-31 | CUE | Suri Anish | Pres AND CSO | F - Tax | $4.88 | -7,068 | 103.6K | -6% | -$34.5K |
| D | 2022-04-04 | 2022-03-31 | CUE | Suri Anish | Pres AND CSO | M - OptEx | — | +16.7K | 110.7K | +18% | — |
| I | 2022-04-04 | 2022-03-31 | CUE | Fletcher Aaron G.L. | Dir | P - Purchase | $4.76 | +735.0K | 735.0K | New | +$3.50M |
| D | 2021-11-17 | 2021-11-15 | CUE | Suri Anish | Pres, CSO | S - Sale+OE | $18.05 | -8,000 | 94.0K | -8% | -$144.4K |
| D | 2021-11-17 | 2021-11-15 | CUE | Suri Anish | Pres, CSO | M - OptEx | $8.26 | +8,000 | 102.0K | +9% | +$66.1K |
| DM | 2021-11-17 | 2021-11-15+ | CUE | Kiener Peter A | Dir | M - OptEx | $2.86 | +20.2K | 1,361 | New | +$57.7K |
| DM | 2021-11-17 | 2021-11-15+ | CUE | Kiener Peter A | Dir | S - Sale+OE | $17.93 | -20.2K | 0 | -100% | -$361.7K |
| D | 2021-11-15 | 2021-11-11 | CUE | Suri Anish | Pres, CSO | S - Sale+OE | $15.07 | -20.0K | 94.0K | -18% | -$301.4K |
| D | 2021-11-15 | 2021-11-11 | CUE | Suri Anish | Pres, CSO | M - OptEx | $6.42 | +20.0K | 114.0K | +21% | +$128.4K |
| D | 2021-10-08 | 2021-10-03 | CUE | Suri Anish | Pres AND CSO | M - OptEx | — | +33.3K | 108.2K | +45% | — |
| D | 2021-10-08 | 2021-10-06 | CUE | Suri Anish | Pres AND CSO | F - Tax | $12.97 | -14.1K | 94.0K | -13% | -$183.3K |
| D | 2021-10-08 | 2021-09-30 | CUE | PASSERI DANIEL R | CEO, Dir | F - Tax | $14.57 | -31.7K | 98.7K | -24% | -$461.5K |
| D | 2021-10-08 | 2021-09-30 | CUE | PASSERI DANIEL R | CEO, Dir | M - OptEx | — | +75.0K | 130.4K | +135% | — |
| DM | 2021-10-05 | 2021-08-23+ | CUE | Millar Kerri-Ann | CFO | M - OptEx | $1.18 | +7,918 | 11.7K | +208% | +$9,382 |
| D | 2021-10-05 | 2021-08-23 | CUE | Millar Kerri-Ann | CFO | F - Tax | $0.00 | -1,961 | 10.5K | -16% | $0 |
| D | 2021-10-05 | 2021-10-01 | CUE | Millar Kerri-Ann | CFO | S - Sale+OE | $14.21 | -1,251 | 10.5K | -11% | -$17.8K |
| D | 2021-09-27 | 2021-09-23 | CUE | Suri Anish | Pres AND CSO | M - OptEx | $6.42 | +20.0K | 94.8K | +27% | +$128.4K |
| D | 2021-09-27 | 2021-09-23 | CUE | Suri Anish | Pres AND CSO | S - Sale+OE | $15.23 | -20.0K | 74.8K | -21% | -$304.6K |
| 2021-09-27 | 2021-09-24 | CUE | PASSERI DANIEL R | CEO, Dir | P - Purchase | $14.72 | +3,400 | 55.4K | +7% | +$50.0K |
Purchase Sale Sale after option exercise All abbreviations